Skip to main content
TENX filings

Corporate insider profile

Daniel Schneeberger Filing Activity

Latest reported as Corporate insider of TENAX THERAPEUTICS, INC. (TENX).

Purchase filings
17
Reported companies
4
Net open-market value
$13,131,494
Latest transaction
Oct 21, 2026

Transaction history

Open-market Transactions

Open-market insider purchase and sale transactions
DateCompanyRoleTypeSharesPriceTotal value
Oct 21, 2026TENAX THERAPEUTICS, INC. (TENX)Corporate insiderOpen Market Purchase922,849$1.59$1,463,454
Oct 19, 2026InMed Pharmaceuticals Inc. (INM)Corporate insiderOpen Market Purchase1,087$1.32$1,435
Oct 15, 2026InMed Pharmaceuticals Inc. (INM)Corporate insiderOpen Market Purchase9,569$1.33$12,719